Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

30,212 total articles

Automakers Press Ahead With New EV Models as U.S. Sales Slide

Automakers Press Ahead With New EV Models as U.S. Sales Slide

Major carmakers introduced new electric vehicles at the New York Auto Show even as U.S. EV sales have softened following the end of a $7,500 federal tax credit. Automakers signaled continued commitment to EVs, citing rising gasoline costs and long-term market recovery timelines, while industry executives warned that near-term demand remains subdued…

OpenAI Purchases Silicon Valley Tech Talk Show TBPN in Unexpected Deal

OpenAI Purchases Silicon Valley Tech Talk Show TBPN in Unexpected Deal

OpenAI has acquired TBPN, an online technology-focused talk show popular in Silicon Valley. Founders John Coogan and Jordi Hays, who launched TBPN in late 2024 to compete with established business news outlets, will join OpenAI as part of the transaction. OpenAI did not disclose financial terms and said the acquisition is intended to improve how it…

Braskem’s Outlook Strengthened by Higher Petrochemical Spreads, But Near-Term Debt Maturities Cast Shadow

Braskem’s Outlook Strengthened by Higher Petrochemical Spreads, But Near-Term Debt Maturities Cast Shadow

Rising petrochemical prices and tighter spreads have improved the operational outlook for Brazil-based Braskem, prompting an analyst price-target increase. However, the company faces near-term interest obligations and mounting debt pressures at its Mexico joint venture, and a delayed ownership transition has left negotiations over its capital struc…

Regeneron Says It Expects Exemption From Proposed U.S. Drug Tariffs

Regeneron Says It Expects Exemption From Proposed U.S. Drug Tariffs

Regeneron Pharmaceuticals said it expects to be left off a proposed U.S. tariff list aimed at drugmakers that have not finalized price-cut agreements with the administration. The company said it expects to announce a deal "in the near future" to reduce prescription costs for Medicaid and cash-paying patients, and remains the only one of 17 firms th…

Jobs Report and Services PMI Headline Packed U.S. Data Slate on Friday

Jobs Report and Services PMI Headline Packed U.S. Data Slate on Friday

Traders face a dense schedule of U.S. economic releases on Friday, April 3, 2026, led by the monthly nonfarm payrolls report and a slate of labor-market indicators, followed by the Services PMI. The data, which include headline payrolls, unemployment, hourly earnings and a range of S&P Global PMIs, offer contemporaneous information on employmen…

Hedge Funds Accelerate Global Equity Selling in March, Hitting 13-Year High

Hedge Funds Accelerate Global Equity Selling in March, Hitting 13-Year High

Hedge funds sold global equities at the fastest clip in 13 years during March, driven largely by a rise in short positions and ETF-based trades, according to data from Goldman Sachs' prime brokerage. The selling accompanied steep monthly declines in major equity benchmarks and was concentrated across economically sensitive sectors, while managers r…

Inovio Shares Plunge After Company Prices Dilutive Offering

Inovio Shares Plunge After Company Prices Dilutive Offering

Inovio Pharmaceuticals' stock fell sharply after the company announced an underwritten public offering of 12,500,000 shares and accompanying warrants priced at $1.40 per share. The structure includes Series A and Series B warrants, an underwriter option for additional shares, and expected gross proceeds of about $17.5 million before fees.

Celldex Announces $300M Equity Offering; Shares Slip

Celldex Announces $300M Equity Offering; Shares Slip

Celldex Therapeutics Inc announced an underwritten public offering of 10,345,000 common shares priced at $29.00 each, sparking a 2.7% decline in the company's stock on Thursday. The company granted underwriters a 30-day option to purchase an additional 1,551,750 shares and said it expects gross proceeds of roughly $300 million before fees. Proceeds…

Google Opens Gemma 4 Model Family Under Apache 2.0 License

Google Opens Gemma 4 Model Family Under Apache 2.0 License

Google has released Gemma 4, a set of open-source AI models distributed under an Apache 2.0 license. The family contains four sizes geared for edge and cloud use, supports long context windows and multimodal inputs, and is available through multiple developer platforms and download sites. Google reports more than 400 million downloads of Gemma mode…

Madrid Stocks Slip as Financials and Consumer Names Weigh on IBEX 35

Madrid Stocks Slip as Financials and Consumer Names Weigh on IBEX 35

Spain's IBEX 35 closed lower on Thursday, sliding 0.14% as losses in Financial Services & Real Estate, Consumer Goods and Building & Construction sectors pressured the market. Gains in energy and telecom names contrasted with notable declines in steel and regional banking stocks. Commodities moved sharply, with crude oil advancing and gold futures …

Portuguese Equities Close Higher; PSI Climbs 0.75% to Five-Year Peak

Portuguese Equities Close Higher; PSI Climbs 0.75% to Five-Year Peak

Portugal's benchmark PSI index finished higher on Thursday, advancing 0.75% to reach a new five-year high. Strength in Consumer Goods, Utilities and Telecoms sectors powered the rise, with energy and renewable stocks among the session leaders. Commodity markets saw pronounced movement, with Brent and front-month crude jumping while gold fell. Curre…